At its investor day, Chevron Corporation (NYSE: CVX) outlined its five-year plan to 2030 and how it intends to deliver sustained cash flow growth, further strengthen its portfolio, advance power ...

Get key Q3 2025 earnings call insights on Cytosorbents (CTSO): growth drivers, FDA progress, cost controls, and outlook.

From misinterpreting financial statements to making uninformed investment decisions, these critical oversights could be draining your company’s lifeblood without you even knowing it. Cash Flow Blind ...

By bne IntelliNews US-based supermajor Chevron unveiled its plans for the next five years at its investor day on November 12.

Lifestyle investing focuses on generating immediate cash flow that exceeds your living expenses, creating freedom now rather ...

If you are eyeing Recursion Pharmaceuticals and wondering whether now is the time to act, you are not alone. The stock just staged a remarkable run, up 20.8% over the past week and soaring 36.0% ...

Denver, CO October 24, 2025 –(PR.com)– The Hong Kong Securities and Futures Commission (SFC) has approved the first Solana spot ETF by China Asset Management (ChinaAMC), with trading set to begin on ...

Universal Electronics Inc. (NASDAQ: UEIC) Q3 2025 Earnings Call Transcript November 6, 2025 Universal Electronics Inc. beats ...

Interest rates may be more likely to come down when the Bank of England (BoE) sets rates in December, with future economic data as well as the Autumn Budget likely to inform the decision. Inflation ...

Chevron projects 10%+ EPS growth, higher free cash flow, and strategic oil and gas expansion. The company targets 2–3% annual oil and gas production growth and $70 Brent breakeven.